|
|
|
|
|
|
|
|
Abstract:
"CONCLUSION: In advanced ovarian cancer patients who achieve a CCR (complete clinical response) following induction chemotherapy, optimal cytoreduction may confer a greater clinical benefit from a maintenance approach compared to suboptimal cytoreduction."
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.